MGI Tech Unveils Cutting-Edge Laboratory Automation Solutions at SLAS 2026 in Vienna

MGI Tech Co., Ltd., a pioneering force in the life sciences sector, made waves at the recent SLAS 2026 conference held in Vienna, Austria, by showcasing its inventive laboratory automation technologies and integrated workflow solutions. This annual event serves as a premier platform for industry leaders, and MGI Tech's presence underscored its commitment to driving innovation in life sciences through advanced tools and technologies.

Showcasing Innovations in Laboratory Automation

At SLAS 2026, MGI Tech introduced a range of intelligent automation solutions designed to streamline research processes and enhance efficiency. The focus was on multi-omics solutions that not only simplify complex workflows but also bolster emerging applications in proteomics and integrated laboratory settings.

Highlights of MGI Tech's Innovations

1. PrepALL-pP8G: Enhancing Single-Cell Proteomics Automation
One of the standout offerings was the PrepALL-pP8G system, an expanded application of the PrepALL platform. This system is tailored for single-cell proteomics, primarily focusing on sample pretreatment. Notably flexible, it seamlessly integrates with other external devices, showcasing its potential for broader applications. Utilizing thermal inkjet printing technology combined with ultra-low volume dispensing, the PrepALL-pP8G ensures a highly automated and efficient workflow, facilitating smooth transitions from single-cell sorting to proteomics sample preparation. With 640 independent nozzles and advanced camera recognition aided by AI, it offers ultra-high throughput processing in just minutes while safeguarding cell viability and protein integrity.

2. GenSIRO48: Leading the Charge in Clinical Automation
Another remarkable innovation on display was the GenSIRO48, an advanced fully automated sample processing system. Marking its first international reveal, this system is designed for a “Sample In, Report Out” workflow, integrating multiple steps such as nucleic acid purification and library purification into a single, streamlined process. Engineered to evolve from manual operations to an unattended, fully automated system, GenSIRO48 supports high-throughput parallel processing of 48 samples, making it indispensable in clinical diagnostics and life science research. This transformative approach streamlines sequencing library preparation significantly, showcasing MGI's commitment to advancing the field of molecular diagnosis and public health.

3. VisiOmics (PMIF-20RS): Advancing Spatial Proteomics Exploration
MGI also unveiled the VisiOmics (PMIF-20RS), a state-of-the-art automated system for staining and imaging that leverages multiplex immune fluorescence technology. Part of its appeal lies in its ability to provide precise spatial protein expression data, critical for tumor analysis and translational research. Integrated with an AI-driven analysis platform, it offers thorough workflows essential for applications in oncology and translational medicine. The official European launch of VisiOmics is expected soon, further amplifying MGI's contribution to advanced laboratory automation.